NCT03592719 (MI-PrEP) is a NA clinical trial of Experimental Intervention (MI-PrEP) in Risk Factor, sponsored by University of Miami.

Who is sponsoring NCT03592719?

NCT03592719 is sponsored by University of Miami.

What drugs are being tested in NCT03592719?

Interventions in NCT03592719: Experimental Intervention (MI-PrEP), Enhanced Treatment as Usual (E-TAU).

What condition does NCT03592719 study?

NCT03592719 studies Risk Factor.

Is NCT03592719 still recruiting?

NCT03592719 is currently completed. Last updated 19 December 2020.

Last reviewed 2020-12-19 · How we verify

NCT03592719: MI-PrEP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Motivational Interviewing to Increase PrEP Uptake (MI-PrEP)

Completed NA Last updated 19 December 2020

What this trial tests

NA trial testing Experimental Intervention (MI-PrEP) in Risk Factor in 50 participants. Completed in 11 November 2019.

Timeline

1 October 2018

Primary endpoint
11 November 2019

11 November 2019

Quick facts

Lead sponsor	University of Miami
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	1 October 2018
Primary completion	11 November 2019
Estimated completion	11 November 2019
Sites	1 location across United States

Drugs / interventions tested

Experimental Intervention (MI-PrEP)
Enhanced Treatment as Usual (E-TAU)

Conditions studied

Risk Factor — all drugs for Risk Factor →

Sponsor

University of Miami

Who can join

18 and older, female only, with Risk Factor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to test a counseling program for Black women at high risk for HIV

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Miami trials

Trials by the same sponsor.

NCT06003712 — Exploring the Effect of Mindfulness on Quality of Life (QoL) in Spinal Cord Injury (SCI) · NA · not yet recruiting
NCT06077071 — MRIdian "RADAR" Trial · NA · not yet recruiting
NCT07472413 — Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot Project · Phase 3 · not yet recruiting
NCT07322289 — Antibiotic-coated Braided Suture Study · NA · not yet recruiting
NCT07469592 — eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03592719 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Miami
Last refreshed: 19 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03592719.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing